These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 9408754)
1. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer. Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754 [TBL] [Abstract][Full Text] [Related]
2. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors. van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173 [TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast. Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258 [TBL] [Abstract][Full Text] [Related]
4. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset). Lo YL; Yu JC; Huang CS; Tseng SL; Chang TM; Chang KJ; Wu CW; Shen CY Int J Cancer; 1998 Dec; 79(6):580-7. PubMed ID: 9842965 [TBL] [Abstract][Full Text] [Related]
5. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors. Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267 [TBL] [Abstract][Full Text] [Related]
6. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers. Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939 [TBL] [Abstract][Full Text] [Related]
7. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836 [TBL] [Abstract][Full Text] [Related]
8. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of BRCA2 gene in sporadic breast tumours. Bièche I; Noguès C; Lidereau R Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873 [TBL] [Abstract][Full Text] [Related]
10. A region close to Tp53 shows LOH in familial breast cancer. Luo L; Chen J; Du Q; Dumanski J; Blennow E; Kockum I; Luthman H; Lindblom A Int J Mol Med; 2002 Apr; 9(4):405-9. PubMed ID: 11891537 [TBL] [Abstract][Full Text] [Related]
11. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Tirkkonen M; Johannsson O; Agnarsson BA; Olsson H; Ingvarsson S; Karhu R; Tanner M; Isola J; Barkardottir RB; Borg A; Kallioniemi OP Cancer Res; 1997 Apr; 57(7):1222-7. PubMed ID: 9102202 [TBL] [Abstract][Full Text] [Related]
12. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777 [TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer. Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281 [TBL] [Abstract][Full Text] [Related]
14. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma. Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988 [TBL] [Abstract][Full Text] [Related]
15. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient. Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424 [TBL] [Abstract][Full Text] [Related]
16. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314 [TBL] [Abstract][Full Text] [Related]
18. Replication error in human breast cancer: comparison with clinical variables and family history of cancer. Huiping C; Johannsdottir JT; Arason A; Olafsdottir GH; Eiriksdottir G; Egilsson V; Ingvarsson S Oncol Rep; 1999; 6(1):117-22. PubMed ID: 9864413 [TBL] [Abstract][Full Text] [Related]
19. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors. Plummer SJ; Paris MJ; Myles J; Tubbs R; Crowe J; Casey G Genes Chromosomes Cancer; 1997 Dec; 20(4):354-62. PubMed ID: 9408751 [TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer. Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]